Boston, MA, United States of America

Osman O Ahsen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osman O Ahsen: Innovator in Intravascular Imaging Technologies

Introduction

Osman O Ahsen is a prominent inventor based in Boston, MA, known for his contributions to medical imaging technologies. He has developed innovative methods that enhance the detection of inflammatory activity within blood vessels, which is crucial for diagnosing cardiovascular diseases.

Latest Patents

Osman O Ahsen holds a patent for an invention titled "Intravascular dual-modality OCT and multichannel NIRF inflammation imaging." This patent describes a method for detecting inflammatory activity by utilizing a catheter equipped with both a near-infrared fluorescence (NIRF) imaging system and an optical coherence tomography (OCT) imaging system. The process involves introducing a near-infrared fluorescent cathepsin-activatable imaging agent into a blood vessel, obtaining structural images of atherosclerotic plaques, and identifying inflammation based on the detected imaging agent.

Career Highlights

Osman O Ahsen is affiliated with The General Hospital Corporation, where he applies his expertise in medical imaging. His work focuses on advancing techniques that improve patient outcomes through better diagnostic tools.

Collaborations

He collaborates with notable colleagues, including Adam Mauskapf and Andrew D Thrapp, who contribute to his research and development efforts in the field of medical imaging.

Conclusion

Osman O Ahsen's innovative work in intravascular imaging technologies exemplifies the importance of advancements in medical diagnostics. His contributions are paving the way for improved detection and treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…